FT : Race for fusion intensifies as UK opens flagship project to investors

Race for fusion intensifies as UK opens flagship project to investors
Government-backed venture moves on to commercial footing to tap surging interest in unproved energy source

The UK government plans to attract private investors to the national nuclear fusion developer to which it has pledged £1.3bn in backing, as it seeks to tap surging investor interest in a technology that holds the prospect of eventually delivering abundant clean energy.

Under a new national fusion strategy announced on Monday, UK Industrial Fusion Solutions, the government’s fusion development arm, will be renamed UK Fusion Energy and restructured to operate “more fully as a commercially oriented entity”.

The company “will provide the foundation for the UK to develop first of a kind fusion power plants and directly stimulate the growth of the UK supply chain”, the fusion strategy said. “Working with industrial partners, UKIFS will develop world-leading capabilities as a fusion power plant integrator that can design and deploy fusion power plants globally, with the capability to raise external investment in future.”

The move marks a shift in the UK’s approach to the commercially unproven technology, which has historically relied heavily on public funding.

Private investors have poured billions of dollars into US fusion start-ups in recent years, with China rapidly catching up, betting the technology could one day supply vast amounts of carbon-free electricity.

Tech sector investors have voiced hopes that fusion could help meet the heavy power demand fuelled by the AI boom, which requires huge amounts of electricity for its calculations. Sceptics, however, argue that commercial fusion is decades away.

UKIFS is currently a wholly owned subsidiary of the UK Atomic Energy Authority, the Oxfordshire-based national fusion laboratory, and is responsible for developing the prototype Spherical Tokamak for Energy Production (Step) reactor planned at the site of a former coal-fired power station in Nottinghamshire.

The fusion industry aims to replicate the reaction that powers the Sun by forcing atomic nuclei to combine in a superheated plasma, unlike nuclear fission, which harnesses energy created when atoms are split.

The Step project aims to demonstrate commercial viability by delivering electricity to the grid by 2040, a milestone no fusion reactor has yet achieved anywhere in the world.

According to a government tender notice issued in 2024, the project could cost up to £20bn.

The government did not say when private investors would be brought into the renamed UK Fusion Energy or how much funding the company would seek.

However, progress on the Step programme could help reduce engineering risks and generate technologies that the company could “exploit commercially”, it said.

The UK’s move comes as global competition to develop fusion power intensifies. US fusion start-ups raised $1.6bn in private funding last year, according to PitchBook.

Meanwhile, China has invested between $6.5bn and $10bn in fusion research since 2022, according to estimates by the Special Competitive Studies Project, a US think-tank chaired by former Google chief executive Eric Schmidt.

>>> Europe : Brokers Upgrades & Downgrades - 16th of March 2026 V3(++)

>>> Up
* AKWEL SADIR Raised to Hold at TP ICAP Midcap; PT 7 euros (++)
* Alcoa PT Raised to $76 from $54 at Citi (++)
* Banca Generali Raised to Outperform at Mediobanca SpA
* Bayer Raised to Buy at UBS; PT 52 euros
* Carlsberg Raised to Buy at Berenberg; PT 1090 kroner
* Daimler Truck Raised to Buy at DZ Bank; PT 52 euros (+)
* Forvia Raised to Buy at TP ICAP Midcap; PT 13 euros (++)
* Hammerson Raised to Overweight at Morgan Stanley; PT 400 pence
* Hemnet Raised to Neutral at UBS; PT 122 kronor
* Ipsen Raised to Neutral at BNP Paribas; PT 160 euros
* Merlin Properties Raised to Overweight at Morgan Stanley
* Naturgy Raised to Neutral at Grupo Santander; PT 28.40 euros
* OKEA Raised to Buy at DNB Carnegie; PT 45 kroner (++)
* Petrobras ADRs Raised to Buy at Banco BTG Pactual; PT $21
* Reckitt Raised to Overweight at Morgan Stanley; PT 6,300 pence
* Royal Unibrew Raised to Buy at Berenberg; PT 681 kroner
* Savills Raised to Buy at Peel Hunt; PT 1,400 pence
* Segro Raised to Overweight at Morgan Stanley; PT 880 pence
* Solstad Maritime Holding Raised to Buy at Clarksons
* SSE PT Raised to 2,850 pence from 2,500 pence at Deutsche Bank (+)
* Stef Raised to Buy at TP ICAP Midcap; PT 141 euros (+)
* System1 Raised to Buy at Canaccord; PT 610 pence (+)
* Valeo Raised to Hold at TP ICAP Midcap; PT 11 euros (++)
* Zurich Ins. Raised to Equal-Weight at Morgan Stanley

>>> Down
* 3U Holding Cut to Hold at SMC Research; PT 1.50 euros (++)
* Anglogold Cut to Equal-Weight at ABSA Securities; PT $113.30
* Beiersdorf Cut to Underweight at Morgan Stanley; PT 77 euros
* Big Yellow Group Cut to Underweight at Morgan Stanley
* Canal+ SA PT Cut to 230 pence from 280 pence at UBS (++)
* Didi Global ADRs Cut to Neutral at Macquarie; PT $3.90
* Dof Group Cut to Neutral at Clarksons; PT 125 kroner
* Henkel Cut to Underweight at Morgan Stanley; PT 66.50 euros
* Kinnevik PT Cut to 65 kronor from 90 kronor at Deutsche Bank (+)
* LondonMetric Cut to Underweight at Morgan Stanley; PT 205 pence
* MARR SpA Cut to Neutral at Banca Akros (ESN); PT 8.50 euros (++)
* MARR SpA Cut to Neutral at Intesa Sanpaolo; PT 10 euros (++)
* National Grid Cut to Sell at UBS; PT 1,160 pence
* Oracle PT Cut to $320 from $400 at Mizuho Securities (++)
* Snam Cut to Neutral at Grupo Santander; PT 7 euros
* Stroeer Cut to Market Perform at Bernstein; PT 36 euros
* Subsea 7 Cut to Hold at Arctic Securities; PT 280 kroner (+)
* Taylor Wimpey Cut to Hold at Stifel; PT 95 pence (+)
* TeamViewer Cut to Equal-Weight at Barclays; PT 5 euros
* Var Energi Cut to Hold at Fearnley; PT 41 kroner (+)
* Voestalpine Cut to Neutral at Oddo BHF; PT 40 euros (++)

>>> Initiation
* Aberdeen Group Rated New Hold at Cavendish; PT 212 pence (+)
* Ashmore Rated New Sell at Cavendish; PT 168 pence (+)
* Impax Asset Rated New Buy at Cavendish; PT 210 pence (+)
* Jupiter Rated New Sell at Cavendish; PT 164 pence (+)
* Liontrust Rated New Buy at Cavendish; PT 415 pence (+)
* Mersen Rated New Buy at Marex; PT 50 euros (++)
* Nebius Rated New Buy at Citi on Growth and Expanding Margins (++)
* Ninety One Rated New Buy at Cavendish; PT 276 pence (+)
* Norconsult Norge Rated New Buy at Arctic Securities
* Polar Capital Rated New Buy at Cavendish; PT 849 pence (+)
* Premier Miton Group PLC Reinstated Buy at Cavendish; PT 67 pence (+)
* WH Smith Rated New Buy at BofA; PT 551 pence (++)
* Zurich Ins. Reinstated Outperform at ZKB (+)

>>> Call
* Canal+ Falls as UBS Sets Street-Low Target on MultiChoice Deal (++)
* Citi Strategists See Europe’s AI Moment Coming; Adopters to Gain (++)
* Goldman’s Oppenheimer Sees Likely Correction But no Bear Market (+)
* LVMH Drops as Morgan Stanley Slashes PT on Murakami, Middle East
* Morgan Stanley’s Wilson Sees Equity Correction Nearing End (+)
* Stroeer Cut to Market Perform at Bernstein Over Non-Core Assets
* Tecan 2026 Outlook to Spur Estimate Downgrades, Analysts Say (+)

WSJ : Nebius, Meta Agree to $27 Billion AI Infrastructure Pact

Nebius, Meta Agree to $27 Billion AI Infrastructure Pact
Nebius said it will provide $12 billion of dedicated capacity across multiple locations

Nebius agreed to a five-year deal worth about $27 billion to supply AI infrastructure capacity to Meta as it continues to see surging demand for its data center computing.

Nebius said it will provide $12 billion of dedicated capacity across multiple locations. Meta also agreed to purchase up to $15 billion in additional available capacity over the five-year period, Nebius said.

Nebius added that it will use large-scale deployments of Nvidia’s next-generation Vera Rubin AI infrastructure platform, which is expected to be available starting in the second half of the year. Nebius will deliver the capacity beginning early next year, it said.

Meta has been investing heavily to expand its AI computing capacity and has signed partnerships with Nvidia and Advanced Micro Devices worth more than $100 billion. It also struck deals earlier this year to make it an anchor customer for new and existing nuclear power in the U.S. needed to fuel its energy-hungry data centers.

Meanwhile, Nebius has seen its position as an AI infrastructure provider surge in recent months as tech companies compete to lock in data center computing capacity to train and run AI models.

In September, it agreed to a $17.4 billion deal with Microsoft to supply AI infrastructure capacity.

Last week, Nvidia agreed to invest $2 billion in Nebius. The two companies will partner to design and deploy large AI data centers and Nebius will gain early access to Nvidia’s latest computing technologies.

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Bayer (BAYRY) upgraded to Buy from Neutral at UBS
    • Carlsberg (CABGY) upgraded to Buy from Hold at Berenberg
    • Circle Internet (CRCL) upgraded to Buy from Hold at Clear Street, tgt $136
    • Ecolab (ECL) upgraded to Buy from Hold at Berenberg, tgt $326
    • Intuit (INTU) upgraded to Neutral from Underperform at BNP Paribas Exane, tgt $463
    • LifeMD (LFMD) upgraded to Outperform from Neutral at Mizuho, tgt $8
    • PennyMac Financial (PFSI) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $115
    • Reckitt Benckiser (RBGLY) upgraded to Overweight from Equal Weight at Morgan Stanley
    • Rocket Companies (RKT) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $22
    • SEACOR Marine Holdings (SMHI) upgraded to Buy from Neutral at Clarksons Platou, tgt $10
    • Simply Good Foods (SMPL) upgraded to Buy from Hold at Jefferies, tgt $22
    • The Trade Desk (TTD) upgraded to Neutral from Sell at Arete, tgt $25
    • Upstart (UPST) upgraded to Buy from Neutral at BTIG Research, tgt $43
  • Downgrades:
    • Adobe (ADBE) downgraded to Hold from Buy at Argus
    • Alnylam (ALNY) downgraded to Hold from Buy at Jefferies, tgt $330
    • Beiersdorf (BDRFY) downgraded to Underweight from Equal Weight at Morgan Stanley
    • BeOne Medicines (ONC) downgraded to Hold from Buy at Jefferies, tgt $290
    • DiDi Global (DIDIY) downgraded to Neutral from Outperform at Macquarie, tgt $3.90
    • Hain Celestial (HAIN) downgraded to Underweight from Equal Weight at Barclays, tgt $0.50
    • Immunocore (IMCR) downgraded to Hold from Buy at Jefferies, tgt $33
    • Incyte (INCY) downgraded to Hold from Buy at Jefferies, tgt $94
    • KinderCare Learning Companies (KLC) downgraded to Underweight from Equal Weight at Barclays, tgt $2
    • National Grid (NGG) downgraded to Sell from Neutral at UBS
    • NewLake Capital Partners (NLCP) downgraded to Neutral from Buy at Compass Point, tgt $15
    • Qualcomm (QCOM) downgraded to Sell from Neutral at Seaport Research, tgt $100
    • Summit Therapeutics (SMMT) downgraded to Hold from Buy at Jefferies, tgt $15
  • Others:
    • Abivax (ABVX) initiated with a Buy at Jefferies, tgt $160
    • Alamo Group (ALG) initiated with an Outperform at William Blair
    • Amalgamated Financial (AMAL) assumed with a Neutral at Piper Sandler, tgt $41
    • Atlassian (TEAM) initiated with an Outperform at BNP Paribas Exane, tgt $95
    • Bar Harbor Bankshares (BHB) assumed with an Overweight at Piper Sandler, tgt $38
    • Beacon Financial (BBT) assumed with an Overweight at Piper Sandler, tgt $33
    • Chain Bridge Bancorp (CBNA) assumed with a Neutral at Piper Sandler, tgt $39
    • Cohu (COHU) initiated with an Outperform at Evercore ISI, tgt $35
    • Columbia Financial (CLBK) assumed with a Neutral at Piper Sandler, tgt $18
    • ConnectOne Bancorp (CNOB) assumed with an Overweight at Piper Sandler, tgt $31
    • Design Therapeutics (DSGN) initiated with a Buy at Jefferies, tgt $15
    • Dime Community (DCOM) assumed with an Overweight at Piper Sandler, tgt $37
    • Eastern Bankshares (EBC) assumed with an Overweight at Piper Sandler, tgt $23
    • Eaton (ETN) reinstated with a Buy at Jefferies, tgt $430
    • Elemental Royalty (ELE) initiated with a Buy at H.C. Wainwright, tgt $32.50
    • Fifth Third Bancorp (FITB) resumed with an Overweight at JPMorgan, tgt $50.50
    • Flagstar Bank (FLG) assumed with an Overweight at Piper Sandler, tgt $16
    • JFrog (FROG) initiated with a Buy at Guggenheim, tgt $60
    • Independent Bank (INDB) assumed with a Neutral at Piper Sandler, tgt $84
    • Lindblad Expeditions (LIND) initiated with an Outperform at Oppenheimer, tgt $25
    • MediciNova (MNOV) initiated with a Buy at H.C. Wainwright, tgt $10
    • NBT Bancorp (NBTB) assumed with an Overweight at Piper Sandler, tgt $50
    • Northeast Bank (NBN) assumed with an Overweight at Piper Sandler, tgt $133
    • Opus Genetics (IRD) initiated with an Outperform at Oppenheimer, tgt $10
    • PayPay (PAYP) initiated with an Outperform at Macquarie, tgt $22.90
    • Peapack-Gladstone Financial (PGC) assumed with an Overweight at Piper Sandler, tgt $39
    • Provident Financial Services (PFS) assumed with an Overweight at Piper Sandler, tgt $25
    • Solid Power (SLDP) initiated with a Buy at H.C. Wainwright, tgt $7
    • Sunbelt Rentals (SUNB) initiated with a Buy at Citigroup, tgt $85
    • Sunbelt Rentals (SUNB) initiated with an Underperform at BofA Securities, tgt $62
    • Washington Trust Bancorp (WASH) assumed with a Neutral at Piper Sandler, tgt $32
    • Western New England Bancorp (WNEB) assumed with a Neutral at Piper Sandler, tgt $14
    • Zevra Therapeutics (ZVRA) initiated with a Buy at BTIG Research, tgt $23

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • ZEPP -9.8%, ZBIO -1.1%
Other news:
  • CE -1.8% (announces a price increase for a range of engineered materials products in response to various factors, including recent market developments and global supply chain disruptions)
  • TLX -0.8% (resubmits NDA for brain cancer imaging agent Pixclara)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • ULH +9.7%, ANRO +9.7%, NIU +3.2%, VNET +2.8%, VFS +1.3%, SAIC +1.2%, OLMA +1%
Other news:
  • CTMX +48.7% (Varsetatug Masetecan (EpCAM PROBODY ADC) continues to demonstrate positive data supporting potential as a new treatment option in late-line colorectal cancer)
  • GPCR +15.7% (reports positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living with obesity and/or overweight with at least one weight related co-morbidity)
  • NBIS +13.9% (signs new AI infrastructure agreement with Meta)
  • ANRO +9.7% (enters into securities purchase agreement with institutional and accredited investors to sell securities in a private placement financing for gross proceeds of approximately $120 mln)
  • NBP +9.5% (receives FDA alignment on accelerated approval pathway for givastomig)
  • SOC +7% (Secretary of Energy Chris Wright directed Sable Offshore Corp. to restore operations of the Santa Ynez Unit and Santa Ynez Pipeline System to address supply disruption risks caused by California policies that have left the region and U.S. military forces dependent on foreign oil; resumes oil flow as ordered by the federal DPA with expected gross oil rate of 50,000 bbls/d and expects first sales by April 1, 2026)
  • HIVE +5.2% (expands Canadian AI data center capacity through BUZZ HPC)
  • MU +4.7% (completes acquisition of Taiwan fab site to expand AI memory capacity)
  • GLSI +4.3% (announces use of commercially manufactured GP2 in FLAMINGO-01)
  • SENS +4.1% (presents first ever real-world evidence of Eversense 365 Presented at ATTD demonstrates sustained performance and positive impact throughout one-year of wear)
  • ENLT +3.6% (announces the financial close for the Crimson Orchard Project)
  • KRRO +3.5% (files for 7,650,764 share common stock offering by selling shareholders)
  • INFQ +3.4% (delivers UK's first operational 100-qubit quantum system)
  • STXS +3.2% (files for $100 mln mixed securities shelf offering)
  • BNC +3.1% (acknowledges request tied to activist board takeover attempt)
  • NESR +2.9% (has secured several, multi-year Cementing contract awards valued at ~ $300 mln)
  • VTS +2.3% (announces hedging update and board member transition)
  • NEO +2.2% (PanTracer LBx test has received coverage from the Centers for Medicare & Medicaid Services' Molecular Diagnostics Services Program)
  • RSKD +1.9% (to repurchase 1 mln Class A ordinary shares from Pitango Venture Capital)
  • MEOH +1.8% (OCI Chemicals B.V. has sold 3,331,346 common shares of Methanex Corporation representing approximately 4.3% of the issued and outstanding Shares) GLUE +1.7% (has entered into a supply agreement with Johnson & Johnson (JNJ) to evaluate MRT-2359 in combination with ERLEADA for the treatment of patients with metastatic castration-resistant prostate cancer with androgen receptor mutations in a planned Phase 2 study expected to initiate in the third quarter of 2026)
  • IRD +1.4% (files for 7,374,632 share common stock offering by selling shareholders)
  • RLAY +1.4% (announces data from Zovegalisib + Fulvestrant at the phase 3 dose of 400mg BID Fed at ESMO targeted anticancer therapies congress 2026)
  • HSTM +1.3% (approves new share repurchase program for up to $10.0 mln of common stock)
  • OWL +1% (unanimously recommends shareholders reject unsolicited minority offer from Cox and Saba)

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • SOC +17%, NBIS +16.2%, ULH +9.7%, MU +4.3%, INFQ +4.2%, HIVE +3.8%, STXS +3.7%, GLSI +3.6%, BNC +3.1%, ENLT +2.9%, VTS +2.3%, NIU +2.1%, RSKD +1.9%, VNET +1.6%, OWL +1.4%, HSTM +1.3%, VFS +1.3%, UGI +1%, SNEX +0.9%, BEKE +0.9%
  • Gapping down:
    • ZEPP -10.4%, ASYS -7.5%, BMEA -0.7%, KRRO -0.6%, WBI -0.6%

>>> Europe : Brokers Upgrades & Downgrades - 16th of March 2026 V2(+)

>>> Up
* Banca Generali Raised to Outperform at Mediobanca SpA
* Bayer Raised to Buy at UBS; PT 52 euros
* Carlsberg Raised to Buy at Berenberg; PT 1090 kroner
* Daimler Truck Raised to Buy at DZ Bank; PT 52 euros (+)
* Hammerson Raised to Overweight at Morgan Stanley; PT 400 pence
* Hemnet Raised to Neutral at UBS; PT 122 kronor
* Ipsen Raised to Neutral at BNP Paribas; PT 160 euros
* Merlin Properties Raised to Overweight at Morgan Stanley
* Naturgy Raised to Neutral at Grupo Santander; PT 28.40 euros
* Petrobras ADRs Raised to Buy at Banco BTG Pactual; PT $21
* Reckitt Raised to Overweight at Morgan Stanley; PT 6,300 pence
* Royal Unibrew Raised to Buy at Berenberg; PT 681 kroner
* Savills Raised to Buy at Peel Hunt; PT 1,400 pence
* Segro Raised to Overweight at Morgan Stanley; PT 880 pence
* Solstad Maritime Holding Raised to Buy at Clarksons
* SSE PT Raised to 2,850 pence from 2,500 pence at Deutsche Bank (+)
* Stef Raised to Buy at TP ICAP Midcap; PT 141 euros (+)
* System1 Raised to Buy at Canaccord; PT 610 pence (+)
* Zurich Ins. Raised to Equal-Weight at Morgan Stanley

>>> Down
* Anglogold Cut to Equal-Weight at ABSA Securities; PT $113.30
* Beiersdorf Cut to Underweight at Morgan Stanley; PT 77 euros
* Big Yellow Group Cut to Underweight at Morgan Stanley
* Didi Global ADRs Cut to Neutral at Macquarie; PT $3.90
* Dof Group Cut to Neutral at Clarksons; PT 125 kroner
* Henkel Cut to Underweight at Morgan Stanley; PT 66.50 euros
* Kinnevik PT Cut to 65 kronor from 90 kronor at Deutsche Bank (+)
* LondonMetric Cut to Underweight at Morgan Stanley; PT 205 pence
* National Grid Cut to Sell at UBS; PT 1,160 pence
* Snam Cut to Neutral at Grupo Santander; PT 7 euros
* Stroeer Cut to Market Perform at Bernstein; PT 36 euros
* Subsea 7 Cut to Hold at Arctic Securities; PT 280 kroner (+)
* Taylor Wimpey Cut to Hold at Stifel; PT 95 pence (+)
* TeamViewer Cut to Equal-Weight at Barclays; PT 5 euros
* Var Energi Cut to Hold at Fearnley; PT 41 kroner (+)

>>> Initiation
* Aberdeen Group Rated New Hold at Cavendish; PT 212 pence (+)
* Ashmore Rated New Sell at Cavendish; PT 168 pence (+)
* Impax Asset Rated New Buy at Cavendish; PT 210 pence (+)
* Jupiter Rated New Sell at Cavendish; PT 164 pence (+)
* Liontrust Rated New Buy at Cavendish; PT 415 pence (+)
* Ninety One Rated New Buy at Cavendish; PT 276 pence (+)
* Norconsult Norge Rated New Buy at Arctic Securities
* Polar Capital Rated New Buy at Cavendish; PT 849 pence (+)
* Premier Miton Group PLC Reinstated Buy at Cavendish; PT 67 pence (+)
* Zurich Ins. Reinstated Outperform at ZKB (+)

>>> Call
* Carlsberg, Royal Unibrew Upgraded at Berenberg on Soft Drinks (+)
* Goldman’s Oppenheimer Sees Likely Correction But no Bear Market (+)
* LVMH Drops as Morgan Stanley Slashes PT on Murakami, Middle East
* Morgan Stanley’s Wilson Sees Equity Correction Nearing End (+)
* Stroeer Cut to Market Perform at Bernstein Over Non-Core Assets
* Tecan 2026 Outlook to Spur Estimate Downgrades, Analysts Say (+)

The Information : What to Expect From GTC: Nvidia’s Groq Chip

It’s party time in San Jose, Calif.! Nvidia on Monday kicks off its annual GTC developer conference in the city, the biggest event on the chip giant’s calendar—which, given the number of public events featuring its CEO, Jensen Huang, is saying something. Huang is scheduled to deliver his keynote tomorrow morning, and it is sure to be a must-watch for people in the AI sector.

One of the biggest things he’s expected to announce is a new chip system that combines Nvidia’s technology with that of Groq, the independent chip firm whose tech Nvidia licensed in a roughly $20 billion deal late last year. This is the first time Nvidia has integrated another company’s AI processor directly into its server racks. Nvidia’s current flagship systems rely almost entirely on its own processors and high-speed interconnects to link the components together.

So why has Nvidia broken the mold for Groq? One reason: inference. That’s the technical term for the process of operating AI models that spit out answers to questions asked by ordinary people, as opposed to the process of training AI models. Nvidia’s chips are outstanding for training models, which is why they’ve been so much in demand in recent years. They’re good at the inference stage as well. But Groq’s chips are tailored for inference, which is going to become an increasing part of AI data center workloads.

Nvidia is expected to name OpenAI as a buyer of the new chip, which could power the AI agent that assists with the firm’s coding tasks. It’s worth noting that assuming Nvidia does unveil the Groq-Nvidia system as expected, it will be quite a departure from Huang’s comment in January that what Nvidia would build with Groq would be “quite unique and quite cool, but it won’t affect our core business.”

Groq’s chip—known as a language processing unit (yes, we have GPUs, TPUs and now LPUs!)—is expected to be mass-produced in the second half of this year at Samsung Electronics’ foundry, according to two people with direct knowledge of Nvidia’s plans. It will be the first time Nvidia has manufactured a server chip outside Taiwan Semiconductor Manufacturing Co., the Taiwanese chipmaker that has supplied virtually all of its flagship AI chips.

Diversifying away from a single supplier makes a lot of sense for Nvidia. But the company plans to eventually move production of the LPU back to TSMC, the people said, as the next generation of LPU will integrate better into a coming version of Nvidia’s next AI chip, we hear.

Here are some technical details of the new Nvidia-Groq system for the AI chip nerds out there. The Nvidia-Groq rack will use a different architecture from that of existing Nvidia racks. It will contain 256 Groq chips in a single rack, and Intel processors will help manage communication between them, according to a person involved in the project—a role Nvidia’s own hardware typically performs in its GPU systems. The decision to use Intel components suggests Nvidia’s existing technologies don’t yet integrate cleanly with the LPU.

Still, this is only the beginning of Nvidia’s plans for Groq’s technology. The company is exploring ways to integrate the LPU more deeply into its future road map for chips. One idea under consideration would be to fuse Groq’s processor with a Feynman GPU—Nvidia’s next generation after Rubin—into a single chip. That would improve performance while lowering costs, according to two people involved in the development. Not that Huang will talk about any of that tomorrow!—Anissa Gardizy and Wayne Ma contributed to this item